Skip to main content

Table 3 Macular pigment optical density (MPOD) response to placebo. See Table 2 for details.

From: Macular pigment response to a supplement containing meso-zeaxanthin, lutein and zeaxanthin

Subject/eye

MPOD pre AU

SD pre AU

Rate of change in MPOD ± SE, mAU/day

p

Significance of rate of change

11/L

0.244

0.034

0.01 ± 0.43

0.99

No signif. change

11/R

0.246

0.055

-0.20 ± 0.26

0.46

No signif. change

12/L

0.570

0.043

-0.99 ± 0.23

0.0001

Signif. decrease

12/R

0.551

0.105

-0.10 ± 0.22

0.65

No signif. change

13/L

0.473

0.065

0.00 ± 0.30

0.99

No signif. change

13/R

0.397

0.077

0.66 ± 0.41

0.12

No signif. change

14/L

0.825

0.067

0.03 ± 0.94

0.98

No signif. change

14/R

0.922

0.186

0.36 ± 0.33

0.30

No signif. change

15/L

0.328

0.050

0.14 ± 0.22

0.53

No signif. change

15/R

0.334

0.058

-0.11 ± 0.24

0.66

No signif. change

16/L

0.492

0.048

-0.72 ± 0.16

<0.0001

Signif. decrease

16/R

0.527

0.022

-0.60 ± 0.18

0.0020

Signif. decrease

17/L

0.579

0.036

-0.64 ± 0.87

0.48

No signif. change

17/R

0.482

0.054

-0.32 ± 0.49

0.52

No signif. change

18/L

0.628

0.041

-0.28 ± 0.30

0.36

No signif. change

18/R

0.625

0.057

0.43 ± 0.28

0.13

No signif. change

19/L

0.739

0.143

-0.44 ± 0.33

0.19

No signif. change

19/R

0.693

0.076

-0.30 ± 0.36

0.41

No signif. change